Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow PROTHENA CORP PUBLIC LTD CO

Get SEC filing alerts via email and in your feed for PROTHENA CORP PUBLIC LTD CO

PRTA

PROTHENA CORP PUBLIC LTD CO

About PROTHENA CORP PUBLIC LTD CO

Prothena Corporation plc is a biotechnology company specializing in protein dysregulation to develop therapies for neurodegenerative and rare amyloid diseases. Its pipeline includes antibody, vaccine, and small molecule programs targeting conditions like Alzheimer’s, Parkinson’s, and amyloidosis. The company leverages deep scientific expertise, strategic collaborations, and innovative targeting of pathogenic proteins to address unmet medical needs in serious, life-threatening diseases.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from PROTHENA CORP PUBLIC LTD CO

1
1
PROTHENA CORP PUBLIC LTD CO Prothena Corporation Reports $51.1 Million Revenue in Q1 2026, Driven by Novo Nordisk Milestone Payment

Via official filing (AI summary) | 29 days ago | 0 comments

2
1
PROTHENA CORP PUBLIC LTD CO Prothena Corporation Reports 93% Revenue Decline and $244.1 Million Net Loss for Fiscal Year 2025

Via official filing (AI summary) | 3 months ago | 0 comments

3
1
PROTHENA CORP PUBLIC LTD CO Prothena Reports Q3 2025 Revenue Increase to $2.4M, Net Loss of $36.5M

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
PROTHENA CORP PUBLIC LTD CO Prothena Reports 97% Revenue Decline and $125.8 Million Net Loss in Q2 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
PROTHENA CORP PUBLIC LTD CO Prothena Reports $2.8 Million Revenue in Q1 2025, Reduces Net Loss

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
PROTHENA CORP PUBLIC LTD CO Prothena Corporation Reports Significant Revenue Decline, Net Loss in Q3 2024, Despite 46% Revenue Growth for Nine Months

Via official filing (AI summary) | over 1 year ago | 0 comments